Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Lazarus who wrote (60662)	4/10/2018 9:16:24 PM
From: E_K_S	Read Replies (3) of 78765

I did another BUY in BGS @ $24.15/share. Sold out my BP that I bought 7/2013 for small gain. Dividend similar but I do think long term growth potential better for BGS. These trades in the ROTH account so preservation of capital important, dividend secondary. Looking at selling some GSK and putting the proceeds into VOD. Both pay similar dividends, each provides for foreign EU exposure but I want to reduce drug/pharma and increase telcom. I still think GSK has good value, low PE but growth better in VOD. I also did another Buy in D (10 pts lower than my first Buy). My trade triggered when yield was 5% @ $65.79/share. USNU late in reporting/filing 10K which is never a good sign. The delayed report was supposed to be filed by April 9. 2018 but that was missed too. EKS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next